Jianjun Zhang

79PUBLICATIONS
498CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersCarbon capture engineering (excl. sequestration)Gene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (79)

|Jul 27, 2026
The genomic landscape and treatment outcomes associated with CDKN2A/MTAP loss in patients with non-small cell lung cancer.

|Jul 08, 2026
Unbiased avidity-based isolation of antigen-specific T cells.

|Jun 13, 2026
Deciphering small sequence differences in T cell receptor-antigen pairing.

|May 18, 2026
Clinical outcomes and predictors of response to PD-(L)1 blockade in patients with NSCLC without actionable genomic alterations who never used tobacco.

|Apr 23, 2026
Real-World Experience of Tarlatamab in Extensive-Stage Small Cell Lung Carcinoma Showed Promising Systemic and Intracranial Efficacy With Higher Neurologic Toxicity.

|Mar 19, 2026
FOXM1-Specific TCR-Engineered T Cells Target Non-Small Cell Lung Cancer.

Emily Bontekoe, Minying Zhang, Peixin Jiang

Pageof 14

Frequent Collaborators

40 joint publications

John Victor Heymach

29 joint publications

Don L Gibbons

29 joint publications

Jack Lee

28 joint publications

Jia Wu